Results 121 to 130 of about 63,264 (143)

Receptor activator of nuclear factor kappa B ligand in an experimental intervertebral disc degeneration.

Clinical and experimental rheumatology, 2009
This study was designed to clarify the role of the receptor activator of nuclear factor kappa B ligand (RANKL) in the process of discus degeneration and spondylarthrosis. It was hypothesized that experimental discus lesion would initiate not only local bone remodelling but also increased osteoclast formation on a location remote to the injury site due ...
Z, Mackiewicz, J, Salo, Y T, Konttinen, A, Kaigle Holm, A, Indahl, J, Pajarinen, S, Holm   +6 more
openaire   +1 more source

Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.

Journal of surgical oncology, 2015
Receptor activator of nuclear factor kappa-B and its ligand (RANK/RANKL) and Osteoprotegerin (OPG) are key molecules for regulating osteoclastic activity in bone. However, little is known about the role of RANK-related molecules in breast cancer prognosis. We aimed to evaluate RANK, RANKL, and OPG expression and the associated clinical impact in breast
Hyung Seok, Park, Ahwon, Lee, Byung Joo, Chae, Ja-Seong, Bae, Byung Joo, Song, Sang Seol, Jung   +5 more
openaire   +1 more source

Evaluation of Receptor Activator of Nuclear Factor Kappa B Ligand, Osteoprotegerin, Osteopontin, and Tumor Necrosis Factor Alpha on Chronic Apical Periodontitis in Smokers

Journal of Endodontics, 2023
Luciana Dias, Fabio Pires, Cinthya Gomes   +2 more
exaly  

Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis.

Clinical and experimental rheumatology, 2009
Ankylosing spondylitis (AS) is an inflammatory arthritis involving the axial skeleton. Decreased bone mineral density has also been reported in AS patients. This study sought to determine whether osteoclastogenesis and osteoclast activity are increased in AS.Twenty patients with AS were evaluated using the Bath Ankylosing Spondylitis Disease Activity ...
C H, Im, E H, Kang, J Y, Ki, D W, Shin, H J, Choi, E J, Chang, E Y, Lee, Y J, Lee, E B, Lee, H H, Kim, Y W, Song   +10 more
openaire   +1 more source

SERUM SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B LIGAND, OSTEOPROTEGERIN, AND SERUM SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B LIGAND/OSTEOPROTEGERIN RATIO IN FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS

European Journal of Internal Medicine, 2011
Alireza Khabazi, Susan Koulahi, Amir Ghorbani Haghjo, null Bustani   +3 more
openaire   +1 more source

Osteoprotegerin and receptor activator of nuclear factor kappa-B ligand levels and their association with BMD in acromegaly

Endocrine Abstracts, 2019
Jowita Halupczok-Żyła, Aleksandra Jawiarczyk-Przybyłowska, Marek Bolanowski   +2 more
openaire   +3 more sources

Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis

Journal of Clinical Periodontology, 2011
Salomon Amar
exaly  

High Expression Levels of Receptor Activator of Nuclear Factor-Kappa B Ligand Associated With Human Chronic Periodontitis Are Mainly Secreted by CD4+T Lymphocytes

Journal of Periodontology, 2006
Jorge Gamonal, Marcela Hernández, Nicolas Dutzan   +2 more
exaly  

Ultraviolet B‐induced immunosuppression is not associated with receptor activator of nuclear factor kappa B ligand upregulation in human skin

Photodermatology, Photoimmunology & Photomedicine, 2018
Etienne Saint‐Cyr Proulx, Shunya Mashiko, Catherine Maari, Chantal Bolduc, Simon Nigen, Marika Sarfati, Robert Bissonnette   +6 more
openaire   +2 more sources

Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis

Clinical Biochemistry, 2010
Sousan Kolahi, Amir Ghorbanihaghjo, Elham Bahreini   +2 more
exaly